Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses

Journal of Immunological Methods

Volumn 291, Issue 1-2, 2004, Pages 153-163

  Negri, Donatella R M ^a   Buffa, Viviana ^a   Leone, Pasqualina ^a   Bona, Roberta ^a   Borghi, Martina ^a   Carlini, Francesca ^a   De Angelis, Fabiana ^a   Indraccolo, Stefano ^b   Ensoli, Barbara ^a   Cara, Andrea ^a  

^a ISS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

AIDS; CTL; Retroviral vector; SHIV SIV; Vaccine

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHROMIUM 51; GAG PROTEIN; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; RETROVIRUS VECTOR; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ASSAY; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG MONITORING; EXPRESSION VECTOR; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS ENVELOPE; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; GENE PRODUCTS, GAG; GENETIC VECTORS; HIV; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; MACACA FASCICULARIS; MALE; SENSITIVITY AND SPECIFICITY; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

ANIMALIA; MACACA FASCICULARIS; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS; VACCINIA VIRUS;

EID: 4444238182     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.05.007     Document Type: Article

References (18)

1. Appay V., Nixon D.F., Donahoe S.M., Gillespie G.M., Dong T., King A., Ogg G.S., Spiegel H.M., Conlon C., Spina C.A., Havlir D.V., Richman D.D., Waters A., Easterbrook P., McMichael A.J., Rowland-Jones S.L. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:2000;63
2. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.M., Wagner W., Bilska M., Craiu A., Zheng X.X., Krivulka G.R., Beaudry K., Lifton M.A., Nickerson C.E., Trigona W.L., Punt K., Freed D.C., Guan L., Dubey S., Casimiro D., Simon A., Davies M.E., Chastain M., Strom T.B., Gelman R.S., Montefiori D.C., Lewis M.G., Emini E.A., Shiver J.W., Letvin N.L. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science. 290:2000;486
3. Bercovici N., Duffour M.T., Agrawal S., Salcedo M., Abastado J.P. New methods for assessing T-cell responses. Clin. Diagn. Lab. Immunol. 7:2000;859
4. Delchambre M., Gheysen D., Thines D., Thiriart C., Jacobs E., Verdin E., Horth M., Burny A., Bex F. The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J. 8:1989;2653
5. + T cell responses in macaques infected with simian immunodeficiency virus. Virology. 272:2000;347
6. Grignani F., Kinsella T., Mencarelli A., Valtieri M., Riganelli D., Grignani F., Lanfrancone L., Peschle C., Nolan G.P., Pelicci P.G. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58:1998;14
7. Kuroda M.J., Schmitz J.E., Barouch D.H., Craiu A., Allen T.M., Sette A., Watkins D.I., Forman M.A., Letvin N.L. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med. 187:1998;1373
8. Letvin N.L., Walker B.D. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat. Med. 9:2003;861
9. Morgenstern J.P., Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:1990;3587
10. Nilsson C., Makitalo B., Berglund P., Bex F., Liljestrom P., Sutter G., Erfle V., ten Haaft P., Heeney J., Biberfeld G., Thorstensson R. Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara. Vaccine. 14:2001;3526
11. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S., Segal J.P., Cao Y., Rowland-Jones S.L., Cerundolo V., Hurley A., Markowitz M., Ho D.D., Nixon D.F., McMichael A.J. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 279:1998;2103
12. Rose N.F., Marx P.A., Luckay A., Nixon D.F., Moretto W.J., Donahoe S.M., Montefiori D., Roberts A., Buonocore L., Rose J.K. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell. 106:2001;539
13. + lymphocytes. Science. 283:1999;857
14. Sun Y., Iglesias E., Samri A., Kamkamidze G., Decoville T., Carcelain G., Autran B. A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J. Immunol. Methods. 15:2003;23
15. Vogel T.U., Fournier J., Sherring A., Ko D., Parenteau M., Bogdanovic D., Mihowich J., Rud E.W. Presence of circulating CTL induced by infection with wild-type or attenuated SIV and their correlation with protection from pathogenic SHIV challenge. J. Med. Primatol. 27:1998;65
16. Weiss R., Teich N., Varmus H., Coffin J. Molecular biology of tumor viruses. RNA Tumor Viruses. 2nd ed.:1982;Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
17. Zhang D., Shankar P., Xu Z., Harnisch B., Chen G., Lange C., Lee S.J., Valdez H., Lederman M.M., Lieberman J. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood. 101:2003;226
18. Zolotukhin A.S., Valentin A., Pavlakis G.N., Felber B.K. Continuous propagation of RRE(-) and Rev(-) RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol. 68:1994;7944